Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 5;10(6):903-913.
doi: 10.1002/mdc3.13738. eCollection 2023 Jun.

Course of Impulse Control Disorder Symptoms in Parkinson's Disease: Deep Brain Stimulation Versus Medications

Pilar Hernandez-Con  1 , Iris Lin  2 , Eugenia Mamikonyan  3 , Wissam Deeb  4 , Robert Feldman  5 , Andrew Althouse  5 , Ryan Barmore  6 , Robert S Eisinger  7   8 , Meredith Spindler  7 , Michael S Okun  8 , Daniel Weintraub  3   7 , Lana M Chahine  9
Affiliations

Course of Impulse Control Disorder Symptoms in Parkinson's Disease: Deep Brain Stimulation Versus Medications

Pilar Hernandez-Con et al. Mov Disord Clin Pract. .

Abstract

Background: The effect of surgery on impulse control disorders (ICDs) remains unclear in Parkinson's disease (PD) patients undergoing deep brain stimulation (DBS).

Objective: To examine changes in ICD symptoms in PD patients undergoing DBS compared to a medication-only control group.

Methods: The study was a 2-center, 12-month, prospective, observational investigation of PD patients undergoing DBS and a control group matched on age, sex, dopamine agonist use, and baseline presence of ICDs. Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS) and total levodopa equivalent daily dose (LEDD) were collected at baseline, 3, 6, and 12 months. Linear mixed-effects models assessed changes in mean QUIP-RS score (sum of buying, eating, gambling, and hypersexuality items).

Results: The cohort included 54 participants (DBS = 26, controls = 28), mean (SD) age 64.3 (8.1) and PD duration 8.0 (5.2) years. Mean baseline QUIP-RS was higher in the DBS group at baseline (8.6 (10.7) vs. 5.3 (6.9), P = 0.18). However, scores at 12 months follow-up were nearly identical (6.6 (7.3) vs. 6.0 (6.9) P = 0.79). Predictors of change in QUIP-RS score were baseline QUIP-RS score (β = 0.483, P < 0.001) and time-varying LEDD (β = 0.003, P = 0.02). Eight patients (four in each group) developed de novo ICD symptoms during follow-up, although none met diagnostic criteria for an impulse control disorder.

Conclusions: ICD symptoms (including de novo symptoms) at 12 months follow-up were similar between PD patients undergoing DBS and patients treated with pharmacological therapy only. Monitoring for emergence of ICD symptoms is important in both surgically- and medication-only-treated PD patients.

Keywords: LEDD; Parkinson's disease; de novo ICDs; deep brain stimulation; dopaminergic medication.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of the study sample: from assessment for the study to the final analytic sample. *Eligible DBS+ patients were PD patients who had surgery scheduled in one of the participating institutions and who could be contacted by the study team prior surgery. Eligible participants for the control group were selected among PD patients who were not expected to require DBS within two years of enrollment in the study. §diagnosis was revised by the clinician’s patient. †no post‐baseline assessment available.
Figure 2
Figure 2
Trends in (A) QUIP‐RS scores and (B) LEDD during follow‐up.
Figure 3
Figure 3
Within‐subject presence/absence of ICD based on QUIP‐RS score.
See this image and copyright information in PMC

References

    1. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al. Impulse control disorders in Parkinson disease: a cross‐sectional study of 3090 patients. Arch Neurol 2010;67(5):589–595. - PubMed
    1. Eisinger RS, Ramirez‐Zamora A, Carbunaru S, Ptak B, Peng‐Chen Z, Okun MS, Gunduz A. Medications, deep brain stimulation, and other factors influencing impulse control disorders in parkinson's disease. Front Neurol 2019;10:86. - PMC - PubMed
    1. Ceravolo R, Frosini D, Rossi C, Bonuccelli U. Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management. Parkinsonism Relat Disord 2009;15(Suppl 4):S111–S115. - PubMed
    1. Weintraub D, David AS, Evans AH, Grant JE, Stacy M. Clinical spectrum of impulse control disorders in Parkinson's disease. Mov Disord 2015;30(2):121–127. - PubMed
    1. Weintraub D, Mamikonyan E. Impulse control disorders in parkinson's disease. Am J Psychiatry 2019;176(1):5–11. - PubMed

LinkOut - more resources